Skip to main content
    X

    XBiotech Inc (XBIT)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $1.78
    -0.07 (-3.78%)

    Market Cap: $59.76M

    Last updated: Nov 17, 2026 at 4:10 PM ET

    XBiotech Inc (XBIT) Statistics

    Updated Nov 17, 2026. Figures from company filings and market prices; estimates from consensus analysts.

    XBiotech (XBIT) has a market cap of $59.76M. It holds $105.04M more cash than debt, 175.78% of its market cap.

    Total Valuation

    Market Cap$59.76M
    Latest price (Nov 17, 2026)$1.78

    Key Dates

    The next earnings report is expected on Mar 11, 2027, covering the quarter ending Dec 31, 2026.

    Next Earnings DateMar 11, 2027 (expected)
    Last Earnings DateNov 12, 2026
    Fiscal Year EndDecember

    Share Statistics

    The share count held steady in the quarter ended Sep 30, 2026 and grew 0.02% a year over 2 years.

    Shares Outstanding30.49M
    Shares Change (YoY)0.00%
    Shares Change (QoQ)0.00%
    Share Count Growth (2Y CAGR)+0.02%

    Price Statistics

    The stock is down 32.58% over 52 weeks and trades 14.01% below its 50-day average.

    Beta (1Y)0.50
    52-Week Change-32.58%
    1-Month Change-11.00%
    3-Month Change-22.94%
    6-Month Change-24.89%
    5-Year Change-87.18%
    10-Year Change-85.81%
    Total Return (1Y)-32.58%
    Total Return (3Y CAGR)-22.37%
    Total Return (5Y CAGR)-32.77%
    Return vs SPY (1Y)-35.81%
    Max Drawdown (1Y)-34.32%
    Max Drawdown (3Y)-82.00%
    Sharpe Ratio (1Y)-0.76
    Correlation with SPY (1Y)0.19
    50-Day Average$2.07
    200-Day Average$2.28
    52-Week Range$1.80 to $2.73
    RSI (14 Days)33.4
    Average Volume (20 Days)78.01K

    The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.

    Price chart

    Financial Position

    Current assets cover 39.51x current liabilities, and total debt is 0.00x shareholder equity.

    Current Ratio39.51x
    Quick Ratio39.51x
    Debt / Equity0.00x

    Returns and Efficiency

    Return on equity is -35.13% over the last 12 months, against a 5-year average of -16.99%.

    Return on Equity (ROE)-35.13%
    Return on Assets (ROA)-33.89%
    ROE (5Y Average)-16.99%
    ROA (5Y Average)-16.05%
    ROIC (5Y Average)-19.73%

    Scores

    XBIT has a Piotroski F-Score of 2 of 9, in the weak band of 0 to 2.

    Piotroski F-Score2 of 9
    Piotroski StrengthWeak

    Income Statement

    Revenue was $0 over the last 12 months.

    Revenue$0
    Gross Profit-$378.00K
    Operating Income-$47.49M
    Pretax Income-$43.38M
    Net Income-$43.59M
    Reported EPS (TTM)-$1.43

    Trailing 12 months through Sep 30, 2026.

    Full financial statements

    Balance Sheet

    Shareholder equity funds 96.46% of the $128.61M in total assets.

    Cash and Equivalents$105.04M
    Total Debt$0
    Net Cash$105.04M
    Net Cash Per Share$3.45
    Working Capital$103.66M
    Shareholder Equity$124.06M
    Book Value Per Share$4.07
    Total Assets$128.61M
    Total Liabilities$4.55M

    Balance sheet as of Sep 30, 2026.

    Full balance sheet

    Cash Flow

    Operating Cash Flow-$40.96M
    FCF Per Share-$1.34
    Depreciation and Amortization$1.26M

    Trailing 12 months through Sep 30, 2026.

    Full cash flow statement

    Growth

    Book Value Per Share Growth (2Y CAGR)-19.98%
    Tangible Book Per Share Growth (2Y CAGR)-19.98%

    Revenue and profit by year

    Price Target

    Analyst price targets are part of paid GNG plans. See plans

    Frequently Asked Questions About XBIT

    What is XBIT's market cap?

    XBiotech has a market cap of $59.76M.

    How many shares of XBIT are outstanding?

    XBiotech has 30.49M shares outstanding. The count is up 0.00% from a year earlier.

    Does XBIT pay a dividend?

    No. XBiotech does not pay a dividend.

    How much debt does XBIT have?

    XBiotech has $0 of total debt and $105.04M of cash and equivalents, a net cash position of $105.04M.